ArticleNPJ biofilms and microbiomes2026

Drug repurposing for glucosyltransferase inhibition for targeted oral biofilm disruption.

Fernanda S de Lucena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.